SAFETY EVALUATION OF DNA VACCINE PVAX1/TSOL18 AGAINST CYSTICERCUS CELLULOSAE

刘斌,才学鹏,郭爱疆,骆学农,陈晓宇,丁军涛,刘英

DOI: https://doi.org/10.3969/j.issn.1674-6422.2008.05.002

2008-01-01

Abstract:Objective The biosafety and tissue distribution of recombinant expression plasmid pVAX1/TSOL18,an anti-cysticercosis DNA vaccine,was investigated in mice. Methods Recombinant pVAX1/TSOL18 plasmid was intramuscularly injected on the legs of mice,which were killed after 1 d,5 d,15 d and 30 d post-injection and the gDNA were extracted from hearts、liver、spleen,etc.at the different time.The distribution and the residual time of recombinant pVAX1/TSOL18 plasmids in the tissue of mice were analyzed by PCR technology.At the same time,the feces of mice were tested by PCR to investigate the release of pVAX1/TSOL18 in the external environment. Results One day and five days after immunization,the target fragments were amplified from the different gDNA of mice tissues.To the different individual,the tissue are also different which the target fragment were amplified from,but from blood of all the injected mice,the target fragment were obtained.Contrast to the result on the first day,the fragment are darker than that on the fifth days.Fifteen days after immunization,there was only one mouse in which the fragment of plasmid TSOL18 gene could be detected.Thirty days later,no any recombinant plasmid could be detected in all the mice.And the TSOL18 plasmid gene were not detected at the first and fifth day in the feces. Conclusion Recombinant plasmid pVAX1/TSOL18 is safe to mice and the surrounding environment as a vaccine.